Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orion Oyj B | Helsinki | Healthcare | Pharmaceuticals | €9.76B | 27.9x | 0.46 | €69.45 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.3% Downside | Upgrade to Pro+ | |
Orion Oyj A | Helsinki | Healthcare | Pharmaceuticals | €9.76B | 28x | 0.46 | €69.10 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terveystalo | Helsinki | Healthcare | Healthcare Providers & Services | €1.31B | 14.8x | 0.04 | €10.38 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Revenio Group | Helsinki | Healthcare | Healthcare Equipment & Supplies | €731.59M | 38.5x | 15.27 | €27.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Pihlajalinna Oy | Helsinki | Healthcare | Healthcare Providers & Services | €338.58M | 11.7x | 0.03 | €15.05 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.2% Upside | Upgrade to Pro+ | |
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €264.03M | -8.1x | -0.27 | €2.45 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.4% Upside | Upgrade to Pro+ | |
Oriola-KD Oyj B | Helsinki | Healthcare | Pharmaceuticals | €203.18M | -8.7x | -4.05 | €1.12 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.6% Upside | Upgrade to Pro+ | |
Detection Technology OY | Helsinki | Healthcare | Healthcare Equipment & Supplies | €161.94M | 14.6x | 0.14 | €11.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €153.29M | -9.6x | -1.76 | €2.54 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €141.46M | -8.6x | 3.78 | €5.73 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -25.8% Downside | Upgrade to Pro+ | |
Nexstim | Helsinki | Healthcare | Healthcare Equipment & Supplies | €97.69M | -64.6x | -3.12 | €13.60 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.5% Downside | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €86.22M | -3.8x | -0.28 | €1.01 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Optomed | Helsinki | Healthcare | Healthcare Equipment & Supplies | €84.24M | -13.2x | 0.65 | €4.29 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
Bioretec Oy | Helsinki | Healthcare | Healthcare Equipment & Supplies | €55.41M | €1.80 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Modulight Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €51.83M | -7.7x | -0.18 | €1.22 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.2% Upside | Upgrade to Pro+ | |
Biohit Oyj B | Helsinki | Healthcare | Pharmaceuticals | €46.01M | 17.9x | 0.44 | €3.03 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €39.52M | -6.7x | 0.01 | €1.64 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.2% Upside | Upgrade to Pro+ |